Form 8-K - Current report:
SEC Accession No. 0001213900-20-026282
Filing Date
2020-09-11
Accepted
2020-09-11 17:08:15
Documents
2
Period of Report
2020-09-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea126736-8k_cmlifesciences.htm 8-K 35970
2 AUDITED BALANCE SHEET AS OF SEPTEMBER 4, 2020 ea126736ex99-1_cmlifesci.htm EX-99.1 109533
  Complete submission text file 0001213900-20-026282.txt   146617
Mailing Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10020
Business Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10020 212 474 6700
CM Life Sciences, Inc. (Filer) CIK: 0001818331 (see all company filings)

IRS No.: 851966622 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39482 | Film No.: 201171683
SIC: 6770 Blank Checks